These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20052366)

  • 1. The L441P mutation of cystic fibrosis transmembrane conductance regulator and its molecular pathogenic mechanisms in a Korean patient with cystic fibrosis.
    Gee HY; Kim CK; Kim SW; Lee JH; Kim JH; Kim KH; Lee MG
    J Korean Med Sci; 2010 Jan; 25(1):166-71. PubMed ID: 20052366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis in Korean children:a case report identified by a quantitative pilocarpine iontophoresis sweat test and genetic analysis.
    Ahn KM; Park HY; Lee JH; Lee MG; Kim JH; Kang IJ; Lee SI
    J Korean Med Sci; 2005 Feb; 20(1):153-7. PubMed ID: 15716623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of a Korean patient with cystic fibrosis, carrying Q98R and Q220X mutations in the CFTR gene.
    Koh WJ; Ki CS; Kim JW; Kim JH; Lim SY
    J Korean Med Sci; 2006 Jun; 21(3):563-6. PubMed ID: 16778407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
    Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
    Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous spectrum of CFTR gene mutations in Korean patients with cystic fibrosis.
    Jung H; Ki CS; Koh WJ; Ahn KM; Lee SI; Kim JH; Ko JS; Seo JK; Cha SI; Lee ES; Kim JW
    Korean J Lab Med; 2011 Jul; 31(3):219-24. PubMed ID: 21779199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation.
    Meng X; Wang Y; Wang X; Wrennall JA; Rimington TL; Li H; Cai Z; Ford RC; Sheppard DN
    J Biol Chem; 2017 Mar; 292(9):3706-3719. PubMed ID: 28087700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.
    Ziedalski TM; Kao PN; Henig NR; Jacobs SS; Ruoss SJ
    Chest; 2006 Oct; 130(4):995-1002. PubMed ID: 17035430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
    Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
    Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel CFTR mutations in a Korean infant with cystic fibrosis and pancreatic insufficiency.
    Choe YJ; Ko JS; Seo JK; Han JJ; Shim JO; Koh YY; Lee R; Ki CS; Kim JW; Kim JH
    J Korean Med Sci; 2010 Jan; 25(1):163-5. PubMed ID: 20052365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and
    Hosseini Nami A; Kabiri M; Zafarghandi Motlagh F; Shirzadeh T; Bagherian H; Zeinali R; Karimi A; Zeinali S
    Ther Adv Respir Dis; 2024; 18():17534666241253990. PubMed ID: 38904297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.
    Antigny F; Norez C; Dannhoffer L; Bertrand J; Raveau D; Corbi P; Jayle C; Becq F; Vandebrouck C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):83-90. PubMed ID: 20203293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic Fibrosis Gene Mutation Frequency Among a Group of Suspected Children in King Hussein Medical Center.
    Al-Abadi B; Al-Hiary M; Khasawneh R; Al-Momani A; Bani-Salameh A; Al-Saeidat S; Al-Khlaifat A; Aboalsondos O
    Med Arch; 2019 Apr; 73(2):118-120. PubMed ID: 31391700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivacaftor treatment of cystic fibrosis patients with the G551D mutation: a review of the evidence.
    Kotha K; Clancy JP
    Ther Adv Respir Dis; 2013 Oct; 7(5):288-96. PubMed ID: 24004658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.
    Mickle JE; Cutting GR
    Clin Chest Med; 1998 Sep; 19(3):443-58, v. PubMed ID: 9759548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of multiplex ARMS and SSCP/HD analysis in molecular diagnosis of cystic fibrosis in Indian patients.
    Ashavaid TF; Kondkar AA; Dherai AJ; Raghavan R; Udani SV; Udwadia ZF; Desai D
    Mol Diagn; 2005; 9(2):59-66. PubMed ID: 16137181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
    Stanton BA
    Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations.
    Kerem E; Rave-Harel N; Augarten A; Madgar I; Nissim-Rafinia M; Yahav Y; Goshen R; Bentur L; Rivlin J; Aviram M; Genem A; Chiba-Falek O; Kraemer MR; Simon A; Branski D; Kerem B
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1914-20. PubMed ID: 9196095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Recurrent and Chronic Pancreatitis as Initial Manifestations of Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Disorders.
    Baldwin C; Zerofsky M; Sathe M; Troendle DM; Perito ER
    Pancreas; 2019 Aug; 48(7):888-893. PubMed ID: 31268981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.